Jun 17 |
Evoke Pharma appoints Mark Kowieski as CFO
|
Jun 17 |
Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI
|
May 16 |
Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference
|
May 15 |
Evoke Pharma GAAP EPS of -$0.17 beats by $0.04, revenue of $1.73M misses by $0.41M
|
May 14 |
Evoke Pharma Reports First Quarter 2024 Financial Results
|
Apr 17 |
Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications
|
Mar 16 |
Evoke Pharma, Inc. (NASDAQ:EVOK): Are Analysts Optimistic?
|
Mar 15 |
Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call Transcript
|
Mar 15 |
Q4 2023 Evoke Pharma Inc Earnings Call
|
Mar 15 |
Evoke Pharma, Inc. (EVOK) Q4 2023 Earnings Call Transcript
|